| 000 | 01806 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518042622.0 | ||
| 264 | 0 | _c20210201 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1559-1174 | ||
| 024 | 7 |
_a10.1007/s12017-019-08550-w _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBastian, Chinthasagar | |
| 245 | 0 | 0 |
_aPreserving Mitochondrial Structure and Motility Promotes Recovery of White Matter After Ischemia. _h[electronic resource] |
| 260 |
_bNeuromolecular medicine _c12 2019 |
||
| 300 |
_a484-492 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xbiosynthesis |
| 650 | 0 | 4 |
_aAging _xpathology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAxonal Transport _xdrug effects |
| 650 | 0 | 4 |
_aAxons _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Ischemia, Brain _xpathology |
| 650 | 0 | 4 |
_aIschemic Stroke _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMitochondrial Dynamics _xdrug effects |
| 650 | 0 | 4 |
_aMitochondrial Proteins _xphysiology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOrnithine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aQuinazolinones _xpharmacology |
| 650 | 0 | 4 |
_aReperfusion Injury _xpathology |
| 650 | 0 | 4 |
_aWhite Matter _xdrug effects |
| 650 | 0 | 4 |
_arho GTP-Binding Proteins _xphysiology |
| 700 | 1 | _aDay, Jerica | |
| 700 | 1 | _aPolitano, Stephen | |
| 700 | 1 | _aQuinn, John | |
| 700 | 1 | _aBrunet, Sylvain | |
| 700 | 1 | _aBaltan, Selva | |
| 773 | 0 |
_tNeuromolecular medicine _gvol. 21 _gno. 4 _gp. 484-492 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12017-019-08550-w _zAvailable from publisher's website |
| 999 |
_c29752772 _d29752772 |
||